BERLIN -- Administering bone-modifying agents (BMAs) every 24 weeks after long-term use was a safe and effective strategy for patients with bone metastases from breast cancer, and also appeared to be ...
While HRT has many benefits for those with osteoporosis, certain side effects may occur that your doctor will need to consider. Osteoporosis is a common concern for people who have been through ...
ARLINGTON, Va., May 23, 2024 — The American Society for Radiation Oncology (ASTRO) published today an updated clinical guideline that details best practices for treating patients who have symptomatic ...
A team of researchers has developed a new biomaterial with high potential in in the treatment of bone lesions or minimal residual disease in multiple myeloma patients. The findings showcase a ...
Breakthroughs, discoveries, and DIY tips sent six days a week. Terms of Service and Privacy Policy. Orthopedic researchers have developed a promising new nanoparticle ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results